drugset / Trial / NCT02794610
Ocular Penetration of Topical Tacrolimus Eye Drops
NaSingle-groupOpen-labelTreatment
Summary
Investigators aim to evaluate the ocular penetration of topical tacrolimus 0.03% eye drops. Topical tacrolimus 0.03% will be instilled into the eyes of patients 15 minutes before cataract surgery. Aqueous samples will be collected at the time of cataract surgery and will be subjected to detection of presence and level of tacrolimus.
Timeline
- Start
- 2016-05
- Primary completion
- 2016-06
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | 0.05 % | Topical |
Indications
No indication recorded.